Clinical Trial Recruitment Industry Data Book Covers Clinical Trial Patient Recruitment, Site Management Organization and Support Services Markets.
The global clinical trial recruitment markets size was estimated at USD 15.7 billion in 2021. The market is expected to expand at a CAGR of 6.1% CAGR (2022-2030).
Grand View Research’s clinical trial recruitment industry data book is a collection of market sizing information & forecasts, legal authorizations, payout/reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
Clinical Trial Patient Recruitment Services Market Insights
The global clinical trial patient recruitment services market size was valued at USD 779.5 million in 2021 and is expected to expand at a CAGR of 8.0% from 2022 to 2030.
The phase III patient recruitment services segment dominated the market with the need for the largest revenue share of 57.1% in 2021. This growth can be attributed to the fact that phase III clinical trials are the most expensive ones and involve a significant number of subjects. The failure rate in this phase is the highest due to the sample size, and the study design requires complex dosing at an optimum level.
In terms of therapeutic areas, the clinical trial patient recruitment services market is classified into respiratory diseases, pain and anesthesia, oncology, central nervous system, cardiovascular, endocrine, anti-infective, and others. The pain and anesthesia segment held the highest market share of 13.7% in 2021.
In terms of age group, the adult (18 - 64 Years) segment held the highest market share of 49.5% in 2021. High shares of the segment are majorly due to the presence of a larger number of participants amidst the age group in the clinical studies conducted so far.
Patient recruitment management includes patient recruitment & registry services, patient retention services, and others (analytics, marketing). Patient recruitment & registry services held 67.7% of the market share in 2021. It is observed that 86% of all trials fail to reach enrolling deadlines, and 30% of phase III trials fail to owe to enrolment difficulties.
Access the Global Clinical Trial Recruitment Industry Data Book, 2022 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competition benchmarking, macro-environmental analyses, and regulatory & technological framework studies
Clinical Trials Site Management Organizations Market Insights
The global clinical trials site management organizations market size was valued at USD 5,572.0 million in 2021 and is anticipated to expand at a CAGR of 6.1% from 2022 to 2030.
The project management segment dominated the market for clinical trial site management organizations and accounted for the largest revenue share of 27.6% in 2021. A clinical trial is considered a large and complex project. Project management involves many complex components and moving parts. These include components such as study design, recruiting, labs, an investigational product, data, materials, and site management.
The CNS segment dominated the market for clinical trial site management organizations and accounted for a revenue share of 16.3% in 2021. The high prevalence of CNS-related issues is contributing to the demand for clinical trials, thereby driving the segment. For instance, the WHO, in 2021, reported that over 55.0 million people have dementia worldwide. The growing geriatric population is one of the key reasons for the high prevalence of dementia.
The phase III segment dominated the clinical trials Site Management Organizations (SMOs) market and accounted for the maximum revenue share of 54.0% in 2021. The segment is likely to remain dominant even during the forecast years. Clinical studies in phase III are more complicated than those in earlier stages; this phase also includes a greater number of patients than other phases, which increases the demand for site management in this phase of clinical trials.
Clinical Trials Support Services Market Insights
The global clinical trials support services market was valued at USD 20.8 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.50% from 2023 to 2030.
Clinical trial site management includes site recruitment, retention, and monitoring. It accounted for the largest market share of 44.5% in 2022 and CAGR at 8.9%. The rising number of clinical trials, high prevalence of chronic diseases, and the increase in the number of CROs offering services are key factors anticipated to drive the market in the coming years.
The phase III segment dominated the market with the largest share of 54.1% in 2022. This growth can be attributed to the fact that phase III clinical trials are the most expensive ones and involve a significant number of subjects. The failure rate in this phase is the highest due to the sample size, and the study design requires complex dosing at an optimum level.
The pharmaceutical & biopharmaceutical companies' sponsor segment dominated the market with the largest revenue share of over 70.3% in 2022. The segment is also anticipated to witness the fastest CAGR from 2021 to 2030. This can largely be attributed to the increasing R&D investments and introduction of new drugs, which have increased in the past two decades. In 2019, the pharmaceutical industry spent USD 83 billion on R&D.
Clinical Trial Recruitment Market – Global Industry Segmentation
Clinical Trial Recruitment Industry, By Sector
- Clinical Trial Patient Recruitment Services Market
- Clinical Trials Site Management Organization Market
- Clinical Trials Support Services Market
Clinical Trial Recruitment Industry, By Service
- Clinical Trial Patient Recruitment Services
- Patient recruitment & Registry Services
- Patient retention
- Others
- Clinical Trials Site Management Organization
- Site Management
- Project management
- Regulatory
- Onsite monitoring
- Others
- Clinical Trials Support Services
- Data Management
- Administrative Staff
- IRB
- Others
Clinical Trial Recruitment Industry, By Phase
- Clinical Trial Patient Recruitment Services
- Phase I
- Phase II
- Phase III
- Phase IV
- Clinical Trials Site Management Organization
- Phase I
- Phase II
- Phase III
- Phase IV
- Clinical Trials Support Services
- Phase I
- Phase II
- Phase III
- Phase IV
Clinical Trial Recruitment Industry, By Therapeutic Areas
- Clinical Trial Patient Recruitment Services
- Respiratory Diseases
- Pain and Anesthesia
- Oncology
- Central Nervous System
- Cardiovascular
- Endocrine
- Anti-Infective
- Others
- Clinical Trials Site Management Organization
- Oncology
- Cardiology
- CNS
- Pain Management
- Endocrine
- Others
Clinical Trial Recruitment Services Industry, By Age Group
- Clinical Trial Patient Recruitment Services
- Child (Birth-17 Years)
- Adult (18 - 64 Years)
- Older Adults (65 Years+)
Clinical Trial Recruitment Services Support Industry, By Sponsor
- Clinical Trials Support Services
- Pharmaceutical & biopharmaceutical companies
- Medical device companies
- Others
Order your copy of the Free Sample of “Clinical Trial Recruitment Industry Data Book - Clinical Trial Patient Recruitment, Site Management Organization and Support Services Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research
Clinical Trial Recruitment Industry Data Book Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Denmark
- Sweden
- Norway
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Singapore
- Australia
- Thailand
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Rest of MEA
Clinical Trial Recruitment Industry Data Book Competitive Landscape
This section in the final deliverables also highlights various initiatives taken by the key companies in the recent past that strongly impacts this market space.
Key players operating in the clinical trial recruitment industry are –
- Antidote
- Clara Health
- Clariness
- BBK Worldwide
- Worldwide Clinical Trials
- Clinical Site Services (CCSi)
- IQVIA
- PPD Inc
- Veristat
- Elligo Health Research
- Charles River Laboratories Inc.
- Eurofins Scientific SE
- IQVIA
- Syneos Health Inc.
- The Pharmaceutical Product Development LLC
- Icon PLC
- WuXi AppTec
- LabCorp
- Alcura
- Parexel International, Clinedge
- WCG
- ClinChoice
- Access Clinical Research
- FOMAT Medical Research INC.
- SGS
- KV Clinical
- SMO-Pharmina
- Xylem Clinical Research
- Aurum Clinical Research
Go through the table of content of Clinical Trial Recruitment Industry Data Book to get a better understanding of the Coverage & Scope of the study
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
